- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Celldex Therapeutics Inc
+ Add to WatchlistCLDX:US
12.3000 USD 0.2300 1.84%As of 20:10:00 ET on 05/23/2013.
Company Profile for Celldex Therapeutics Inc (CLDX)
Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.
Contact Information
Celldex Therapeutics Inc
119 Fourth Avenue
Needham, MA 02494
United States
Key Executives for Celldex Therapeutics Inc (CLDX)
| Anthony Salvatore MarucciPresident/CEO | Avery W Catlin "Chip"Senior VP/CFO/Secretary |
| Thomas DavisSenior VP/Chief Medical Ofcr | Tibor KelerSenior VP/Chief Scientific Ofcr |
| Ronald A PepinSenior VP/Chief Business Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page